A Study About the Selection of Time for Retreatment of Helicobacter Pylori After Eradication Failure
NCT05493644 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 660
Last updated 2022-08-09
Summary
The patients who accepted the quadruple eradication program of the helicobacter pylori but failed to eradicate helicobacter pylori will be assessed the most suitable re-eradication time of helicobacter pylori.
Conditions
- Helicobacter Pylori Infection
Interventions
- OTHER
-
Remedial treatment within 3 months
Remedial therapy was performed within 3 months
- OTHER
-
Remedial treatment within 3 to 6 months
Remedial therapy was performed within 3 to 6 months
- OTHER
-
Remedial treatment within 6 to 12 months
Remedial therapy was performed within 6 to 12 months
- OTHER
-
Remedial treatment after 12 months
Remedial therapy was performed after 12 months
Sponsors & Collaborators
-
Shandong University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2023-08-31
- Completion
- 2023-12-31
More Related Trials
-
Quadruple Therapy Versus Dual Therapy as Rescue Regimens for Helicobacter Pylori Infection
NCT01805934 ·Status: COMPLETED ·Phase: PHASE2
-
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
NCT03565484 ·Status: UNKNOWN ·Phase: PHASE4
-
Bismuth-containing Quadruple Therapy for Helicobacter Pylori Eradication
NCT07167511 ·Status: COMPLETED
-
The Efficacy of Quadruple Therapy Containing Sodium Bicarbonate as the Primary Treatment for Helicobacter Pylori Infection
NCT06591494 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection
NCT05718609 ·Status: UNKNOWN ·Phase: PHASE4
-
High-Dose Dual Therapy for H. Pylori Eradication (RETRO-HP Study)
NCT07121205 ·Status: COMPLETED
-
Efficacy and Safety of 14-day Concomitant Therapy for Refractory Helicobacter Pylori Infection
NCT05133193 ·Status: UNKNOWN ·Phase: NA
-
Optimal Duration of Antimicrobial Susceptibility Test (AST) Guided Rescue Therapy for Helicobacter Pylori Infection
NCT02934048 ·Status: UNKNOWN ·Phase: PHASE4
-
Study the Effect of Probiotics Combined With Bismuth Quadruple Rescue Therapy on H Pylori Infective Patients
NCT03297242 ·Status: UNKNOWN
-
A Multi-center Study for Eradication of Refractory Helicobacter Pylori
NCT02741414 ·Status: UNKNOWN ·Phase: NA
-
Eradication Rate Between 1- and 2-Week Helicobacter Pylori Eradication Therapy
NCT02487511 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Different Acid Suppressors in Bismuth-containing Quadruple Therapy Against Helicobacter Pylori
NCT05301725 ·Status: COMPLETED
-
Efficacy and Safety of 14-day Concomitant Therapy for Helicobacter Pylori Infection
NCT04991584 ·Status: UNKNOWN ·Phase: NA
-
Helicobacter Pylori Eradication and Follow-up
NCT05061732 ·Status: RECRUITING ·Phase: PHASE4
-
Community-based Helicobacter Pylori Eradication
NCT00155389 ·Status: UNKNOWN ·Phase: PHASE4
-
Prospective Study : Helicobacter Pylori Eradication Therapy in Accordance With Past Antibiotics Use
NCT01938534 ·Status: UNKNOWN ·Phase: PHASE4
-
Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection
NCT05176821 ·Status: UNKNOWN ·Phase: NA
-
Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori
NCT02776371 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT05332444 ·Status: RECRUITING ·Phase: PHASE4
-
Optimized-dose Amoxicillin Versus Standard-dose Amoxicillin for Quadruple Therapy in Helicobacter Pylori Eradication
NCT05635942 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection
NCT05419674 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacies of Antimicrobial Susceptibility-Guided Versus Empirical Therapy for Rescue Treatment of Helicobacter Pylori Infection
NCT03658746 ·Status: COMPLETED ·Phase: PHASE4
-
Bismuth Quadruple Therapy With Cefuroxime for Helicobacter Pylori Eradication Treatment
NCT04723472 ·Status: SUSPENDED ·Phase: NA
-
Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
NCT02483715 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection
NCT03616405 ·Status: UNKNOWN ·Phase: PHASE4